EMA signs deal to receive reports on misuse of psychoactive substances
This article was originally published in SRA
Executive Summary
The European Medicines Agency will receive reports from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on the misuse of medicinal products as part of a new agreement signed between the two organisations1,2.